Pharmaceutical companies’ poor quality control on their imported medicines

Multinational pharmaceutical companies were criticized for poorly managing their imported medicines.

According to the Ministry of Food and Drug Safety(MFDS), there has been an increasing number of multinational pharmaceutical companies that are imposed an administrative measure of import and sales suspension for quality issue.

Bayer Korea was humiliated from getting a fine for 1-month import ...